108 related articles for article (PubMed ID: 15321029)
21. Nanodispersion-loaded mucoadhesive polymeric inserts for prolonged treatment of post-operative ocular inflammation.
Morsi N; Ghorab D; Refai H; Teba H
J Microencapsul; 2017 May; 34(3):280-292. PubMed ID: 28420308
[TBL] [Abstract][Full Text] [Related]
22. Effects of topical antiglaucoma eye drops on prostaglandin E(2)-induced aqueous flare elevation in pigmented rabbits.
Hayasaka Y; Hayasaka S; Zhang XY; Nagaki Y
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1142-5. PubMed ID: 11923258
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (acular LS) and nepafenac 0.1% (nevanac) in patients undergoing phacoemulsification.
Bucci FA; Waterbury LD; Amico LM
Am J Ophthalmol; 2007 Jul; 144(1):146-7. PubMed ID: 17601444
[TBL] [Abstract][Full Text] [Related]
24. Effect of preoperative eyedrops on cytokine concentrations in aqueous humor of patients undergoing femtosecond laser-assisted cataract surgery.
Lee JH; Chung HS; Moon SY; Yoon J; Lee K; Lee H; Kim JY; Lim HT; Tchah H
Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):885-891. PubMed ID: 34625847
[TBL] [Abstract][Full Text] [Related]
25. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery.
Morsi N; Ghorab D; Refai H; Teba H
Int J Pharm; 2016 Jun; 506(1-2):57-67. PubMed ID: 27091293
[TBL] [Abstract][Full Text] [Related]
26. Stability indicating HPLC-DAD method for analysis of Ketorolac binary and ternary mixtures in eye drops: Quantitative analysis in rabbit aqueous humor.
El Yazbi FA; Hassan EM; Khamis EF; Ragab MAA; Hamdy MMA
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():218-225. PubMed ID: 29080492
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic comparison of ketorolac after intracameral, intravitreal, and suprachoroidal administration in rabbits.
Wang M; Liu W; Lu Q; Zeng H; Liu S; Yue Y; Cheng H; Liu Y; Xue M
Retina; 2012; 32(10):2158-64. PubMed ID: 23099451
[TBL] [Abstract][Full Text] [Related]
28. Ocular effects of topical administration of the phosphodiesterase III inhibitor milrinone in rabbits and cats.
Lee KC; Silver PJ; Bode DC; Gherezghiher T
Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):527-34. PubMed ID: 8309316
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandins, nonsteroidal anti-inflammatory agents and eye disease.
Podos SM
Trans Am Ophthalmol Soc; 1976; 74():637-60. PubMed ID: 194383
[TBL] [Abstract][Full Text] [Related]
30. Ocular hypotensive mechanism of intravitreally injected brain natriuretic peptide in rabbit.
Takashima Y; Taniguchi T; Yoshida M; Haque MS; Yoshimura N; Honda Y
Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2671-7. PubMed ID: 8977481
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of blood-aqueous humor barrier breakdown with diclofenac. A fluorophotometric study.
Kraff MC; Sanders DR; McGuigan L; Raanan MG
Arch Ophthalmol; 1990 Mar; 108(3):380-3. PubMed ID: 2178597
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of steroid action in ocular inflammation: Inhibition of prostaglandin production.
Floman N; Zor U
Invest Ophthalmol Vis Sci; 1977 Jan; 16(1):69-73. PubMed ID: 319076
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of indomethacin 0.1% eye drops compared with ketorolac 0.5% eye drops in the management of ocular inflammation after cataract surgery.
Weber M; Kodjikian L; Kruse FE; Zagorski Z; Allaire CM
Acta Ophthalmol; 2013 Feb; 91(1):e15-21. PubMed ID: 22970738
[TBL] [Abstract][Full Text] [Related]
34. Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model.
Gordon SM; Brahim JS; Rowan J; Kent A; Dionne RA
Clin Pharmacol Ther; 2002 Aug; 72(2):175-83. PubMed ID: 12189364
[TBL] [Abstract][Full Text] [Related]
35. Intravitreal ketorolac for chronic uveitis and macular edema: a pilot study.
Kim SJ; Doherty TJ; Cherney EF
Arch Ophthalmol; 2012 Apr; 130(4):456-60. PubMed ID: 22491916
[TBL] [Abstract][Full Text] [Related]
36. Effect of dipyridamole on prostaglandin-induced ocular hypertension in rabbits.
Podos SM
Invest Ophthalmol Vis Sci; 1979 Jun; 18(6):646-8. PubMed ID: 447464
[TBL] [Abstract][Full Text] [Related]
37. Effects of a cyclic AMP phosphodiesterase inhibitor, 8'-pivaloyloxymethyl ester of griseolic acid, on aqueous humor dynamics in rabbits.
Kiuchi Y; Mishima HK; Araie M
Jpn J Ophthalmol; 1991; 35(1):23-9. PubMed ID: 1654474
[TBL] [Abstract][Full Text] [Related]
38. PD128,907 induces ocular hypotension in rabbits: involvement of D2/D3 dopamine receptors and brain natriuretic peptide.
Chu E; Socci R; Chu TC
J Ocul Pharmacol Ther; 2004 Feb; 20(1):15-23. PubMed ID: 15006155
[TBL] [Abstract][Full Text] [Related]
39. Fluorophotometric study of intravenous carbonic anhydrase inhibitors in rabbits.
Yablonski ME; Hayashi M; Cook DJ; Chubak G; Sirota M
Invest Ophthalmol Vis Sci; 1987 Dec; 28(12):2076-82. PubMed ID: 3679755
[TBL] [Abstract][Full Text] [Related]
40. The influence of topical corticosteroid therapy upon polymorphonuclear leukocyte distribution, vascular integrity and ascorbate levels in endotoxin-induced inflammation of the rabbit eye.
Williams RN; Paterson CA
Exp Eye Res; 1987 Feb; 44(2):191-8. PubMed ID: 3582506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
